CORRESP

PULSE BIOSCIENCES, INC.

3957 Point Eden Way

Hayward, California 94545



August 19, 2020

 

Via EDGAR

 

U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE

Washington, D.C. 20549-3561

Attention:

Ms. Laura Crotty



 

Re:

Pulse Biosciences, Inc.



Registration Statement on Form S-3



Filed August 14, 2020



File No. 333-246346



 



Acceleration Request



Requested Date: August 21, 2020



Requested Time: 4:00 p.m. Eastern Time

 



Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Pulse Biosciences, Inc. (the Company) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-246346) (the Registration Statement), be declared effective at the Requested Date and Requested Time set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the staff of the Securities and Exchange Commission.

The Company hereby authorizes Andrew D. Hoffman of Wilson Sonsini Goodrich & Rosati, P.C., counsel for the Company, to make such request on the Company’s behalf.

The Company requests that it be notified of the effectiveness of the Registration Statement by contacting Andrew D. Hoffman at (650) 849-3240 or ahoffman@wsgr.com.  





 

Sincerely,

 

 

 

PULSE BIOSCIENCES, INC.



By:

 /s/ Sandra A. Gardiner

 

 

Sandra A. Gardiner

Chief Financial Officer, Executive Vice President of Finance and Administration, Secretary and Treasurer



cc:Darrin R. Uecker, Pulse Biosciences, Inc.

Andrew D. Hoffman, Esq., Wilson Sonsini Goodrich & Rosati, P.C.